isoxazoles has been researched along with Polymyalgia Rheumatica in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diamantopoulos, AP; Hetland, H; Myklebust, G | 1 |
Braunert, L; Bruegel, M; Niederwieser, D; Pfrepper, C; Thiery, J | 1 |
Adizie, T; Borg, F; Christidis, D; Dasgupta, B; Dharmapaliah, C | 1 |
3 other study(ies) available for isoxazoles and Polymyalgia Rheumatica
Article | Year |
---|---|
Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
Topics: Adrenal Cortex Hormones; Aged; Female; Giant Cell Arteritis; Giant Cells; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Polymyalgia Rheumatica | 2013 |
[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Hemophilia A; Humans; Isoxazoles; Leflunomide; Male; Polymyalgia Rheumatica; Prednisone; Rituximab; Treatment Outcome | 2010 |
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Polymyalgia Rheumatica; Prospective Studies; Recurrence; Treatment Outcome | 2012 |